Murase, Kazuyuki

Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox

Kikuchi, S., Kobune, M., Iyama, S., Sato, T., Murase, K., Kawano, Y., Takada, K., Ono, K., Kaneko, Y., Miyanishi, K., et al. (2012) · Free Radical Biology and Medicine

Iron Metabolism and DisordersAcute Myeloid Leukemia Research

Cited by 56

The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma

Kamihara, Y., Takada, K., Sato, T., Kawano, Y., Murase, K., Arihara, Y., Kikuchi, S., Hayasaka, N., Usami, M., Iyama, S., et al. (2016) · Oncotarget

Multiple Myeloma Research and TreatmentsIron Metabolism and Disorders

Cited by 45

Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer

Nakamura, H., Takada, K., Arihara, Y., Hayasaka, N., Murase, K., Iyama, S., Kobune, M., Miyanishi, K., & Kato, J. (2019) · Cancer Gene Therapy

Genomics, phytochemicals, and oxidative stressRedox biology and oxidative stress

Cited by 29

Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myeloma

Arihara, Y., Takada, K., Kamihara, Y., Hayasaka, N., Nakamura, H., Murase, K., Ikeda, H., Iyama, S., Sato, T., Miyanishi, K., et al. (2017) · Oncotarget

Multiple Myeloma Research and TreatmentsCell death mechanisms and regulation

Cited by 28

MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model

Sakamoto, H., Miyanishi, K., Tanaka, S., Ito, R., Hamaguchi, K., Sakurada, A., Sato, M., Kubo, T., Osuga, T., Murase, K., et al. (2021) · Scientific Reports

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 8